Literature DB >> 7400276

Electron-capture gas chromatographic assay for metoclopramide in plasma.

L M Ross-Lee, M J Eadie, F Bochner, W D Hooper, J H Tyrer.   

Abstract

An original electron-capture gas chromatographic assay has been developed for the quantiation of metoclopramide in human plasma. The method involves derivatization with heptafluorobutyryl imidazole after alkaline extraction, acid backwash, and a further alkaline extraction. Plasma levels of metoclopramide as low as 5 micrograms/l can be measured using 1 ml of plasma, and no interference from related substances or commonly prescribed drugs has been found. The percentage recovery of drug from plasma ranges from 88% to virtually 100%, and the between-run variation in the assay is 4.3%. The assay has been used for the study of metoclopramide pharmacokinetics in man following intravenous single-dose administration. The resultant plasma concentration vs. time curve was biexponential, with a terminal half-life of 5.0 h, and a distribution half-time of 0.3 h.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7400276     DOI: 10.1016/s0378-4347(00)81691-6

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Aspirin pharmacokinetics in migraine. The effect of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; V Heazlewood; F Bochner; J H Tyrer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Single-dose pharmacokinetics of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; W D Hooper; F Bochner
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 4.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.